Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen‐Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis

  • José Alcaraz‐Quiles
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Mireia Casulleras
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Karl Oettl
    Institute of Physiological Chemistry, Center of Physiological Medicine,Medical University of Graz,Graz,Austria
  • Esther Titos
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Roger Flores‐Costa
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Marta Duran‐Güell
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Cristina López‐Vicario
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain
  • Marco Pavesi
    European Foundation for the Study of Chronic Liver Failure (EF‐CLIF),Barcelona,Spain
  • Rudolf E. Stauber
    Division of Gastroenterology and Hepatology, Department of Internal Medicine,Medical University of Graz,Graz,Austria
  • Vicente Arroyo
    European Foundation for the Study of Chronic Liver Failure (EF‐CLIF),Barcelona,Spain
  • Joan Clària
    Department of Biochemistry and Molecular Genetics,Hospital Clínic‐IDIBAPS,Barcelona,Spain

Description

<jats:p>Decompensated cirrhosis is characterized by exuberant systemic inflammation. Although the inducers of this feature remain unknown, the presence of circulating forms of oxidized albumin, namely human nonmercaptalbumin 1 (HNA1) and HNA2, is a common finding in cirrhosis. The aim of this study was to explore the ability of these oxidized albumin forms to induce systemic inflammation by triggering the activation of peripheral leukocytes. We observed significantly higher plasma levels of HNA1 and HNA2 in patients with cirrhosis (n = 256) compared to healthy volunteers (n = 48), which gradually increased during the course from compensated to decompensated to acute‐on‐chronic liver failure. Plasma HNA1 and HNA2 levels significantly correlated with inflammatory markers (i.e., interleukin‐6 [IL‐6], IL‐1β, tumor necrosis factor‐alpha [TNF‐α] and IL‐8) in patients with cirrhosis. To directly test the inflammatory effects of HNA1 and HNA2 on leukocytes, these oxidized albumin forms were prepared <jats:italic toggle="yes">ex vivo</jats:italic> and their posttranslational modifications monitored by liquid chromatography (LC)–quadrupole time‐of‐flight/mass spectrometry (MS). HNA1, but not HNA2, increased IL‐1β, IL‐6, and TNF‐α mRNA and protein expression in leukocytes from both healthy volunteers and patients with cirrhosis. Moreover, HNA1 up‐regulated the expression of eicosanoid‐generating enzymes (i.e., cyclooxygenase‐2 [COX‐2] and microsomal prostaglandin E [PGE] synthase 1) and the production of inflammatory eicosanoids (PGE<jats:sub>2</jats:sub>, PGF<jats:sub>2α</jats:sub>, thromboxane B<jats:sub>2</jats:sub>, and leukotriene B<jats:sub>4</jats:sub>), as determined by LC–electrospray ionization–MS/MS. The inflammatory response to HNA1 was more pronounced in peripheral blood mononuclear cells (PBMCs) and marginal in polymorphonuclear neutrophils. Kinome analysis of PBMCs revealed that HNA1 induced the phosphorylation of p38 mitogen‐activated protein kinase, the inhibition of which blocked HNA1‐induced cytokine and COX‐2 induction. <jats:italic toggle="yes">Conclusion:</jats:italic> HNA1 triggers an inflammatory response in PBMCs, providing a rationale for its removal and replacement by reduced albumin in the prevention of systemic inflammation in patients with advanced liver disease.</jats:p>

Journal

  • Hepatology

    Hepatology 68 (5), 1937-1952, 2018-10-13

    Ovid Technologies (Wolters Kluwer Health)

Citations (3)*help

See more

Report a problem

Back to top